Candida Research Today is a free monthly online journal that collates and summarizes the latest research about Candida, including details on thrush infections, yeast, diet, treatment, symptoms.

Volume 2 (2005), Issue 6 (June)

1. Rational strategy for the production of new crude lipases from Candida rugosa.
   Biotechnol Lett, 27(7): 499-503. [Abstract] [Full-text]
2. Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001.
   Eur J Clin Microbiol Infect Dis, 24(5): 329-33. [Abstract] [Full-text]
3. A kinetic model for suspended and attached growth of a defined mixed culture.
   Biotechnol Prog, 21(3): 720-7. [Abstract] [Full-text]
4. Comparison of PCR-DGGE and selective plating methods for monitoring the dynamics of a mixed culture population in synthetic brewery wastewater.
   Biotechnol Prog, 21(3): 712-9. [Abstract] [Full-text]
5. Creating space for large secondary alcohols by rational redesign of Candida antarctica lipase B.
   Chembiochem, 6(6): 1051-6. [Abstract] [Full-text]
6. Biomass production from glutamate fermentation wastewater by the co-culture of Candida halophila and Rhodotorula glutinis.
   Bioresour Technol, 96(13): 1522-4. [Abstract] [Full-text]
7. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
   J Biochem (Tokyo), 137(5): 625-32. [Abstract] [Full-text]
8. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
   Oral Microbiol Immunol, 20(4): 226-32. [Abstract] [Full-text]
9. Microbicidal efficacy of ozonated water against Candida albicans adhering to acrylic denture plates.
   Oral Microbiol Immunol, 20(4): 206-10. [Abstract] [Full-text]
10. Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.
    Oral Microbiol Immunol, 20(4): 199-205. [Abstract] [Full-text]
11. The formin family protein CaBni1p has a role in cell polarity control during both yeast and hyphal growth in Candida albicans.
    J Cell Sci, 118: 2637-48. [Abstract] [Full-text]
12. Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.
    J Med Microbiol, 54: 647-53. [Abstract] [Full-text]
13. ABG1, a novel and essential Candida albicans gene encoding a vacuolar protein involved in cytokinesis and hyphal branching.
    Eukaryot Cell, 4(6): 1088-101. [Abstract] [Full-text]
14. A genome sequence survey shows that the pathogenic yeast Candida parapsilosis has a defective MTLa1 allele at its mating type locus.
    Eukaryot Cell, 4(6): 1009-17. [Abstract] [Full-text]
15. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
    Exp Dermatol, 14(7): 551-8. [Abstract] [Full-text]
16. Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2.
    J Pept Res, 66(1): 19-26. [Abstract] [Full-text]
17. Frequency, species and molecular characterization of oral Candida in hosts of different age in China.
    J Oral Pathol Med, 34(6): 352-6. [Abstract] [Full-text]
18. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans.
    J Antimicrob Chemother, 55(6): 905-13. [Abstract] [Full-text]
19. Mitochondrial alterations and autofluorescent conversion of Candida albicans induced by histatins.
    Microsc Res Tech, 66(5): 219-28. [Abstract] [Full-text]
20. Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence.
    J Biol Chem, 280(24): 23408-15. [Abstract] [Full-text]
21. First reported case of endocarditis caused by Candida dubliniensis.
    J Clin Microbiol, 43(6): 3023-6. [Abstract] [Full-text]
22. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures.
    J Clin Microbiol, 43(6): 2909-12. [Abstract] [Full-text]
23. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.
    J Clin Microbiol, 43(6): 2729-35. [Abstract] [Full-text]
24. Flow cytometry susceptibility testing for the antifungal caspofungin.
    J Clin Microbiol, 43(6): 2586-9. [Abstract] [Full-text]
25. Effect of low-level laser therapy on Candida albicans growth in patients with denture stomatitis.
    Photomed Laser Surg, 23(3): 328-32. [Abstract] [Full-text]
26. Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus.
    Clin Exp Immunol, 141(1): 29-36. [Abstract] [Full-text]
27. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p.
    Curr Biol, 15(12): 1150-5. [Abstract] [Full-text]
28. Candida albicans biofilms: more than filamentation.
    Curr Biol, 15(12): R453-5. [Abstract] [Full-text]
29. Reduced adherence of Candida to silane-treated silicone rubber.
    J Biomed Mater Res B Appl Biomater, 74(1): 481-7. [Abstract] [Full-text]
30. Biotransformations for the production of the chiral drug (S)-Duloxetine catalyzed by a novel isolate of Candida tropicalis.
    Appl Microbiol Biotechnol, 67(6): 771-7. [Abstract] [Full-text]
31. (R)-phenylacetylcarbinol production in aqueous/organic two-phase systems using partially purified pyruvate decarboxylase from Candida utilis.
    Biotechnol Bioeng, 91(2): 190-8. [Abstract] [Full-text]
32. Cells of Candida utilis for in vitro (R)-phenylacetylcarbinol production in an aqueous/octanol two-phase reactor.
    Biotechnol Lett, 27(8): 575-81. [Abstract] [Full-text]
33. Adherence of Candida albicans to glow-discharge modified acrylic denture base polymers.
    J Oral Rehabil, 32(7): 518-25. [Abstract] [Full-text]
34. T-profiler: scoring the activity of predefined groups of genes using gene expression data.
    Nucleic Acids Res, 33: W592-5. [Abstract] [Full-text]
35. Prevention of the cryptic epitope SLAYGLR within osteopontin does not influence susceptibility to Candida albicans infection.
    Antimicrob Agents Chemother, 49(7): 3053-5. [Abstract] [Full-text]
36. Drug-induced regulation of the MDR1 promoter in Candida albicans.
    Antimicrob Agents Chemother, 49(7): 2785-92. [Abstract] [Full-text]
37. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
    Antimicrob Agents Chemother, 49(7): 2583-8. [Abstract] [Full-text]
38. Dectin-1 escape by fungal dimorphism.
    Trends Immunol, 26(7): 352-4. [Abstract] [Full-text]
39. Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients.
    Mycopathologia, 159(4): 515-20. [Abstract] [Full-text]
40. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.
    Mycopathologia, 159(4): 501-7. [Abstract] [Full-text]
41. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.
    J Invest Dermatol, 125(1): 108-15. [Abstract] [Full-text]
42. Expression of one-hybrid fusions with Staphylococcus aureus lexA in Candida albicans confirms that Nrg1 is a transcriptional repressor and that Gcn4 is a transcriptional activator.
    Fungal Genet Biol, 42(8): 676-83. [Abstract] [Full-text]
43. A surprisingly large RNase P RNA in Candida glabrata.
    RNA, 11(7): 1064-72. [Abstract] [Full-text]

© 2004-2008 Candida Research Today. All Rights Reserved.